دورية أكاديمية
أعرض في EDS

Calibration of the Dutch EyeQ to Measure Vision Related Quality of Life in Patients With Exudative Retinal Diseases.

التفاصيل البيبلوغرافية
العنوان: Calibration of the Dutch EyeQ to Measure Vision Related Quality of Life in Patients With Exudative Retinal Diseases.
المؤلفون: Rausch-Koster TP; Amsterdam UMC, Vrije Universiteit Amsterdam, Ophthalmology, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands.; Bergman Clinics, Department of Ophthalmology, The Netherlands., Luijten MAJ; Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Child and Adolescent Psychiatry & Psychosocial Care, Amsterdam Reproduction and Development, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands.; Department of Epidemiology and Data Science, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands., Verbraak FD; Amsterdam UMC, Vrije Universiteit Amsterdam, Ophthalmology, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands., van Rens GHMB; Amsterdam UMC, Vrije Universiteit Amsterdam, Ophthalmology, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands., van Nispen RMA; Amsterdam UMC, Vrije Universiteit Amsterdam, Ophthalmology, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands.
المصدر: Translational vision science & technology [Transl Vis Sci Technol] 2022 Apr 01; Vol. 11 (4), pp. 5.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Association for Research in Vision and Ophthalmology Country of Publication: United States NLM ID: 101595919 Publication Model: Print Cited Medium: Internet ISSN: 2164-2591 (Electronic) Linking ISSN: 21642591 NLM ISO Abbreviation: Transl Vis Sci Technol Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Rockville, Md. : Association for Research in Vision and Ophthalmology
مواضيع طبية MeSH: Quality of Life* , Retinal Diseases*, Calibration ; Ethnicity ; Humans ; Surveys and Questionnaires
مستخلص: Purpose: This study aims to develop an item-bank to measure vision-related quality of life (Vr-QoL) and subsequently calibrate this set of items.
Methods: Three Vr-QoL instruments were searched for suitable items to be added in the EyeQ. Patients who received antivascular endothelial growth factor treatment for various retinal diseases involving macular edema were included in the study and completed the 47-item EyeQ. Item response theory (IRT) was used to calibrate the EyeQ items, which was performed multiple times in subsets as a novel approach, containing 80% of the data. Differential item functioning (DIF) was evaluated for various variables.
Results: Responses of 704 patients were used in analysis. One item violated the local independence IRT-assumption and showed a high percentage of missing values, after which this item was deleted from the item-bank. The data of the five subsets fitted the graded response model adequately, and no DIF was detected for items between subsets, after which mean item parameters were calculated. Item fit statistics were found to be good. DIF was detected for gender, age, and administration mode by the patient (independently vs. with help), this involved three items, which all showed negligible impact on total scores.
Conclusions: Because of separate calibrations of the EyeQ in multiple subsets, a high robustness of item parameters is expected.
Translational Relevance: The calibrated EyeQ can now be used for the assessment of Vr-QoL in patients suffering from exudative retinal diseases and is promising for use as a computer adaptive test.
References: Ophthalmology. 2018 Aug;125(8):1149-1159. (PMID: 29548645)
Gerontologist. 2011 Dec;51(6):798-808. (PMID: 21737397)
Arthritis Care Res (Hoboken). 2021 Jul 30;:. (PMID: 34328696)
Pain Med. 2021 Jul 25;22(7):1669-1675. (PMID: 33944948)
Qual Life Res. 2007;16 Suppl 1:5-18. (PMID: 17375372)
Curr Epidemiol Rep. 2019 Jun 15;6:174-183. (PMID: 31840016)
Transl Vis Sci Technol. 2020 Jun 03;9(7):3. (PMID: 32832210)
Qual Life Res. 2020 Mar;29(3):765-774. (PMID: 31707693)
J Patient Rep Outcomes. 2021 Jan 5;5(1):1. (PMID: 33403643)
Health Policy. 1990 Dec;16(3):199-208. (PMID: 10109801)
Lancet Glob Health. 2021 Feb;9(2):e144-e160. (PMID: 33275949)
Psychol Bull. 1948 Nov;45(6):507-29. (PMID: 18893224)
BMC Med Res Methodol. 2011 Sep 02;11:125. (PMID: 21888648)
Acta Ophthalmol. 2021 Sep;99(6):e884-e892. (PMID: 33354933)
Cochrane Database Syst Rev. 2020 Jan 27;1:CD006543. (PMID: 31985055)
Optom Vis Sci. 2010 Apr;87(4):285-93. (PMID: 20142792)
Am J Ophthalmol. 2000 Dec;130(6):793-802. (PMID: 11124300)
J Pers Assess. 2016;98(3):223-37. (PMID: 26514921)
Ned Tijdschr Geneeskd. 2005 Jul 9;149(28):1574-8. (PMID: 16038162)
Arch Ophthalmol. 2001 Jul;119(7):1050-8. (PMID: 11448327)
Ophthalmology. 2001 Oct;108(10):1893-900; discussion 1900-1. (PMID: 11581068)
Health Qual Life Outcomes. 2009 Feb 25;7:18. (PMID: 19243624)
J Patient Rep Outcomes. 2018 Sep 15;2:42. (PMID: 30294712)
Patient. 2014;7(1):23-35. (PMID: 24403095)
Optom Vis Sci. 2007 Nov;84(11):1024-30. (PMID: 18043421)
J Stat Softw. 2011 Mar 1;39(8):1-30. (PMID: 21572908)
Health Qual Life Outcomes. 2021 Sep 27;19(1):226. (PMID: 34579721)
Invest Ophthalmol Vis Sci. 2017 Dec 1;58(14):6379-6387. (PMID: 29260195)
Patient Relat Outcome Meas. 2019 Jan 24;10:9-24. (PMID: 30774489)
Eval Health Prof. 2017 Mar;40(1):79-105. (PMID: 28705028)
Assessment. 2011 Sep;18(3):263-83. (PMID: 21697139)
Med Care. 2007 May;45(5 Suppl 1):S22-31. (PMID: 17443115)
تواريخ الأحداث: Date Created: 20220405 Date Completed: 20220407 Latest Revision: 20220614
رمز التحديث: 20221213
مُعرف محوري في PubMed: PMC8994198
DOI: 10.1167/tvst.11.4.5
PMID: 35380613
قاعدة البيانات: MEDLINE
الوصف
تدمد:2164-2591
DOI:10.1167/tvst.11.4.5